enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Luspatercept - Wikipedia

    en.wikipedia.org/wiki/Luspatercept

    Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. [ 5 ] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication .

  3. Geron's blood disorder drug gets FDA advisers' backing - AOL

    www.aol.com/news/gerons-blood-disorder-drug-gets...

    Imetelstat, if approved, will be Geron's first commercial treatment in the market and will compete with Bristol Myers Squibb's Reblozyl, which received a label expansion by the FDA last year for ...

  4. US FDA staff raises concerns on Geron's blood disorder drug - AOL

    www.aol.com/news/us-fda-staff-flags-concerns...

    (Reuters) -The U.S. Food and Drug Administration's staff reviewers said on Tuesday they were unclear if Geron's blood disorder drug provided a clear benefit to patients in a late-stage trial and ...

  5. Myelodysplastic syndrome - Wikipedia

    en.wikipedia.org/wiki/Myelodysplastic_syndrome

    A myelodysplastic syndrome (MDS) is one of a group of cancers in which blood cells in the bone marrow do not mature, and as a result, do not develop into healthy blood cells. [3] Early on, no symptoms typically are seen. [3] Later, symptoms may include fatigue, shortness of breath, bleeding disorders, anemia, or frequent infections. [3]

  6. In one study reported this year, a specific blood test was around 90% accurate in identifying Alzheimer’s in patients with cognitive symptoms seen in primary care and at specialized memory care ...

  7. Inflammatory demyelinating diseases of the central nervous ...

    en.wikipedia.org/wiki/Inflammatory_demyelinating...

    Inflammatory demyelinating diseases (IDDs), sometimes called Idiopathic (IIDDs) due to the unknown etiology of some of them, are a heterogenous group of demyelinating diseases - conditions that cause damage to myelin, the protective sheath of nerve fibers - that occur against the background of an acute or chronic inflammatory process.

  8. Muscle Loss In This Area Could Be a Key Indicator of ... - AOL

    www.aol.com/muscle-loss-area-could-key-130000809...

    Dementia is a devastating condition that impacts up to 10 percent of older adults. And while there's no cure, getting diagnosed early can help patients get on a treatment plan and families prepare ...

  9. Promyelocyte - Wikipedia

    en.wikipedia.org/wiki/Promyelocyte

    Myelodysplastic Syndromes (MDS) are a group of disorders characterized by ineffective hematopoiesis or dysplasia changes in some myeloid lineages of the bone marrow. Abnormalities in promyelocyte maturation may contribute to pathogenesis of MDS and its associated complications. [ 6 ]